Tag: genital warts market forecast

Uncover key drivers, emerging technologies, and competitive movements shaping the genital warts market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Genital Warts Market?

The genital warts market has experienced robust expansion in recent years. It is projected to increase from $2.06 billion in 2025 to $2.17 billion in 2026, at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historic period can be attributed to the high prevalence of HPV infections, the availability of topical drugs, the early adoption of ablative procedures, sexual health awareness programs, and clinical treatment guidelines.

The genital warts market is anticipated to show substantial growth in the upcoming years. It is projected to expand to $2.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This expansion during the forecast period can be attributed to broader hpv vaccination coverage, the emergence of new topical agents, an increase in outpatient treatment options, early detection campaigns, and patients favoring non-invasive care. Key trends for this period include a growing acceptance of topical treatment methods, enhanced awareness of hpv-related infections, an increasing call for minimally invasive ablative treatments, the expansion of preventive hpv vaccination programs, and greater utilization of home-based treatment alternatives.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Drivers Are Supporting The Rise Of The Genital Warts Market?

The rising occurrence of sexually transmitted infections (STIs) is expected to fuel the expansion of the genital warts market. STIs are contagions primarily spread through various forms of sexual contact, such as vaginal, anal, and oral sex, originating from bacteria, viruses, or parasites. The increasing number of sexually transmitted infections is attributed to factors like heightened sexual activity, insufficient protective measures, and restricted availability of educational resources and health services. As a frequent STI, genital warts stem from particular human papillomavirus (HPV) strains and are transmitted via direct skin-to-skin contact during sexual encounters. Illustrating this trend, the Centers for Disease Control and Prevention, a US-based government public health agency, disclosed in September 2025 that over 2.2 million cases of chlamydia, gonorrhea, and syphilis were recorded in 2024. Consequently, the expanding prevalence of sexually transmitted infections (STIs) is a key factor propelling the growth of the genital warts market.

What Leading Segments Are Studied In The Genital Warts Market?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

How Are Emerging Trends Affecting The Progression Of The Genital Warts Market?

Leading companies in the genital warts market are creating innovative treatment options, such as new dermatology drugs, to address the difficulties encountered by patients with the condition. Dermatology drugs denote recently developed pharmaceuticals or therapeutic agents specifically designed to treat various dermatologic ailments, including genital warts. For example, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, was granted New Chemical Entity (NCE) status for its drug candidate YCANTH. YCANTH is being developed to treat genital warts and has successfully completed phase 2 trials. With this FDA NCE status, the company now has at least five years of protection from generic competition.

Which Key Players Are Driving Competition In The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co. Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, ANI Pharmaceuticals Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ Global AB, Cassiopea Inc, GlaxoSmithKline plc, Pfizer Inc, Bayer AG, Astellas Pharma Inc, Amgen Inc, Boehringer Ingelheim, Johnson & Johnson, Eli Lilly and Company, Novan Inc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Region Currently Holds The Largest Share Of The Genital Warts Market?

North America was the largest region in the genital warts market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genital Warts Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Browse Through More Reports Similar to the Global Genital Warts Market 2026, By The Business Research Company

Vaginal Sling Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaginal-sling-global-market-report

Warts Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/warts-therapeutics-global-market-report

Genital Herpes Market Report 2026

https://www.thebusinessresearchcompany.com/report/genital-herpes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Genital Warts Market Be Worth By 2029?

In recent times, a steady increase has been observed in the genital warts market size. The market, that was worth $1.97 billion in 2024, is expected to reach a value of $2.06 billion the following year, exhibiting a compound annual growth rate (CAGR) of 4.7%. The surge during the historical period is believed to be due to heightened attention towards patient-oriented healthcare, earlier detection and treatment, broader accessibility of self-targeted therapies, and a rise in the number of clinical tests as well as instances of genital warts recurrence.

In the coming years, the genital warts market is predicted to experience significant growth, reaching a value of $2.52 billion in 2029 with a compound annual growth rate (CAGR) of 5.1%. The expected growth within the forecast period can be credited to various factors like the embracement of telemedicine and digital health platforms for remote consultations and monitoring of treatment procedures, increasing need for affordable and effective treatments for sexually transmitted infections, the rising popularity of loop electrosurgical excision procedures, mounting demand for interferon alfa-n3 injections along with the growing availability of treatments. The forecast period also highlights key trends including technological advancement in diagnosing, a shift towards the usage of combined therapies, the growth of telehealth and online consultation services, the development of new therapeutic targets, as well as the growing expansion in emerging markets.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Key Factors Are Fueling Growth In The Genital Warts Market?

The escalating occurrence of sexually transmitted infections (STIs) acts as a catalyst for the expansion of the genital warts market. Sexually transmitted infections (STIs), primarily spread through sexual intercourse, including vaginal, anal and oral, are triggered by pathogens like bacteria, viruses or parasites. The increased number of STIs globally is a result of factors such as rising sexual activity, insufficient use of protection and inadequate access to both educational and medical facilities. Specific strains of the human papillomavirus (HPV) cause genital warts, which is a common sexually transmitted infection (STI). Skin-to-skin contact during sexual intercourse spreads these. For instance, data from the Joint United Nations Programme on HIV/AIDS, based in Switzerland, exhibit that nearly 38.7 million people were HIV positive in 2021. This number escalated to 39.0 million in 2022, with a startling addition of 1.3 million individuals newly infected in the same year. Consequently, the surge in the incidence of sexually transmitted infections (STIs) is propelling the development of the genital warts market.

Which Segmentation Factors Are Critical In The Genital Warts Market Analysis?

The genital wartsmarket covered in this report is segmented –

1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid

2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments

3) By Gender: Female; Male

4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%

What Are The Dominant Trends Currently Seen In The Genital Warts Market?

Leading enterprises in the genital warts market are advancing new treatment choices such as innovative dermatology drugs, aiming to tackle the problems experienced by genital warts patients. Dermatology drugs are cutting-edge pharmaceuticals or therapeutic products exclusively created for managing various dermatologic conditions including genital warts. For example, in March 2023, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical firm based in the US, earned New Chemical Entity (NCE) status for its drug candidate called YCANTH. YCANTH, which is currently under development for treating genital warts, has completed phase 2 trials. The FDA NCE status provides the company with a minimum of five years shield against generic competition.

Which Players Are Shaping The Competitive Landscape Of The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Genital Warts Market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Browse Through More Reports Similar to the Global Genital Warts Market 2025, By The Business Research Company

Cryogenic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Pump Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

Cryogenic Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Genital Warts Industry In 2025?

The genital warts market has experienced consistent growth in recent years. It is anticipated to expand from $1.97 billion in 2024 to $2.06 billion in 2025, at a compound annual growth rate (CAGR) of 4.7%. This historical growth can be linked to several factors, including an increased focus on patient-centered care, a heightened emphasis on early detection and treatment, the growing availability of therapies developed for self-target applications, and a rise in both clinical trials and the recurrence of genital warts.

The genital warts market is projected to experience substantial expansion over the upcoming years, with an anticipated growth to $2.52 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.1%. Key drivers contributing to this growth during the forecast period include the uptake of telemedicine and digital health platforms for distant consultations and treatment oversight, an increasing need for potent and cost-effective STI treatments, the rising prominence of loop electrosurgical excision procedures, a surge in demand for interferon alfa-n3 injection, and the expanding availability of various therapies. Significant trends expected throughout this period encompass improvements in diagnostic technologies, a move towards combination therapies, wider adoption of telehealth and virtual consultations, the identification of new therapeutic targets, and market penetration into developing regions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Drivers Are Impacting The Genital Warts Market?

The rising prevalence of sexually transmitted infections (STIs) is a key factor propelling the expansion of the genital warts market in the future. Sexually transmitted infections are diseases primarily passed through sexual contact, including vaginal, anal, and oral sex, and are caused by bacteria, viruses, or parasites. The incidence of these infections is increasing due to heightened sexual activity, inadequate use of protective measures, and limited access to educational and healthcare services. Genital warts are a common STI resulting from specific strains of the human papillomavirus (HPV) and spread through direct skin-to-skin contact during sexual activity. For instance, data from October 2023, provided by the Joint United Nations Programme on HIV/AIDS, a Switzerland-based global program focused on HIV prevention, revealed that in 2021, roughly 38.7 million individuals were infected with HIV, a number that grew to 39.0 million people in 2022, with 1.3 million new infections reported in 2022. Thus, the growing occurrence of sexually transmitted infections (STIs) is driving the growth of the genital warts market.

What Are The Major Segment Types Covered In The Genital Warts Market?

The genital wartsmarket covered in this report is segmented –

1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid

2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments

3) By Gender: Female; Male

4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%

Which Key Trends Are Expected To Influence The Genital Warts Market In The Coming Years?

Key companies active in the genital warts market are creating innovative treatment methods, such as new dermatology drugs, to help patients overcome the difficulties associated with genital warts. Dermatology drugs describe recently developed pharmaceuticals or therapeutic agents specifically intended for treating various skin conditions, including genital warts. For example, in March 2023, Verrica Pharmaceuticals Inc., a US-based dermatology pharmaceutical company, obtained New Chemical Entity (NCE) status for its drug candidate YCANTH. YCANTH is under development for treating genital warts and has finished phase 2 trials. With FDA NCE status, the company now benefits from at least five years of protection against generic competition.

Who Are The Key Multinational Companies Dominating The Genital Warts Market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

How Does The Genital Warts Market Perform Across Key Geographic Regions?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Genital Warts Market Report:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Browse Through More Reports Similar to the Global Genital Warts Market 2025, By The Business Research Company

Cryogenic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Pump Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-pump-global-market-report

Cryogenic Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Genital Warts Market Size Shifted, And What Is the Outlook Through 2034?

The market for genital warts has been displaying consistent growth over the past few years. The progression from a value of $1.97 billion in 2024 to an estimated $2.06 billion in 2025 signifies a Compound Annual Growth Rate (CAGR) of 4.7%. Factors that have bolstered this growth during the historic phase include a heightened emphasis on patient-oriented care, a push towards early diagnosis and treatment, the rising accessibility of self-target therapies, and an increase in clinical trials and recurrence of genital warts.

The market for genital warts is predicted to experience robust expansion in the coming years, increasing to$2.52 billion in 2029″ at a compound annual growth rate (CAGR) of 5.1%. This growth within the forecast period may result from the implementation of telemedicine and digital health interfaces for distanced consultations and treatment observations, rising need for effective and economical therapies for STIs, growing interest in loop electrosurgical excision methods, surging demand for interferon alfa-n3 injections, and wider availability of treatments. Notable trends throughout the forecast period comprise advancements in diagnostic technologies, movement towards combined therapies, spreading of telehealth and internet-based consultations, emergence of innovative therapeutic objectives, and enlargement in upcoming markets.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Factors and External Forces Are Driving Demand in the Genital Warts Market?

The escalating occurrence of sexually transmitted infections (STIs) is a primary factor contributing to the expansion of the genital warts market. STIs are primarily contracted through sexual activities, such as vaginal, anal, and oral sex, and are the result of bacteria, viruses, or parasites. The rising rate of STIs can be attributed to the increase in sexual activity, improper use of protection, and restricted access to education and healthcare. Genital warts, resulting from specific strains of the human papillomavirus (HPV), are a frequently observed STI and they spread via direct skin contact during sexual interaction. Case in point, the Joint United Nations Programme on HIV/AIDS, a comprehensive global initiative based in Switzerland to prevent the spread of HIV, reported in October 2023 that about 38.7 million individuals were infected with HIV in 2021. This number escalated to 39.0 million in 2022 with 1.3 million fresh cases recorded in the same year. Consequently, the escalating prevalence of STIs is fostering the expansion of the genital warts market.

Which Segments in the Genital Warts Offer the Most Growth?

The genital wartsmarket covered in this report is segmented –

1) By Drug Type: Imiquimod; Podophyllin; Podofilox; Trichloroacetic Acid

2) By Treatment: Chemical Treatment; Ablative Treatment; Preventive Treatment; Other Treatments

3) By Gender: Female; Male

4) By End Users: Hospitals; Clinics; Home Care Settings

Subsegments:

1) By Imiquimod: Imiquimod Cream 5%; Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%; Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%; Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%; Trichloroacetic Acid 50-70%

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Genital Warts Market?# Market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theGenital Warts Market’s Growth?

Leading businesses in the genital warts market are creating innovative treatment choices like advanced dermatology medications to tackle the difficulties experienced by those with genital warts. Dermatology drugs are new pharmaceuticals or therapeutic compounds designed specifically for different skin conditions, including genital warts. For example, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical company based in the United States, garnered New Chemical Entity (NCE) recognition for its drug YCANTH in March 2023. YCANTH, which has completed phase 2 trials, is under development for genital warts treatment. With its FDA NCE status, the firm is guarded from generic competition for at least five years.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

What Are the Key Elements That Define the Genital Warts Market?

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the genital warts industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Genital Warts Market In 2029?

The market for genital warts has seen robust expansion in the past few years. Projections show that it will rise from $1.97 billion in 2024 to $2.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. This growth during the historical phase can be related to the attention on patient-oriented care, the rising importance placed on early identification and treatment, growing accessibility of self-targeting therapies, and the increase in clinical trials as well as the recurrence of genital warts.

Expectations are high for the genital warts market, with robust growth anticipated in the coming years. It’s projected that the market will expand to $2.57 billion by 2029, rising at a compound annual growth rate (CAGR) of 5.4%. This substantial growth slated for the forecast period can be linked to several factors including the widespread adoption of telemedicine and digital health platforms for remote consultations and treatment follow-ups, the mounting demand for both affordable and effective treatments for sexually transmitted infections, the rising popularity of loop electrosurgical excision procedures, the intensifying demand for interferon alfa-n3 injections, and the growing accessibility to therapies. In the forecast period, major trends expected to shape the market include technological advancements in diagnostics, a move towards combination therapy strategies, a surge in telehealth use and online consultations, the introduction of new therapeutic targets, and market expansion in emerging economies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Genital Warts Market?

The escalation in cases of sexually transmitted infections (STIs) is propelling the expansion of the genital warts market. STIs predominantly spread via sexual cavity activities such as vaginal, anal, and oral and are triggered by bacteria, viruses or parasites. The escalating incidence of STIs is tied to heightened sexual activity, improper use of protective measures and inadequate access to education or healthcare facilities. Genital warts, a frequent type of STI, are produced by particular strands of the human papillomavirus (HPV), passed on by direct skin contact during sexual engagement. For instance, data from the Joint United Nations Programme on HIV/AIDS, a comprehensive global programme based in Switzerland aimed to prevent HIV, stated that HIV affected around 38.7 million people in 2021. This figure rose to 39.0 million in 2022, with an added 1.3 million new infections recorded in that year. Therefore, the soaring cases of STIs are fuelling the expansion of the genital warts market.

Which Segments in the Genital Warts Offer the Most Growth?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Which Areas Are Leading Regions in the Genital Warts Market Expansion Across the Globe?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Genital Warts Market Over the Coming Years?

Leading businesses within the genital warts market are innovating new treatment methods, such as cutting-edge dermatology medications, to combat the problems encountered by genital warts patients. Dermatology medications relate to modern pharmaceuticals or therapeutic tools crafted explicitly to tackle numerous dermatologic issues like genital warts. For instance, Verrica Pharmaceuticals Inc., a notable dermatology pharmaceutical firm from the US, attained New Chemical Entity (NCE) recognition for their drug prospect YCANTH in March 2023. YCANTH, which is under development for genital warts treatment, has finalised phase 2 trials. The company is now shielded from generic rivalry for at least the subsequent five years, thanks to its FDA NCE status.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

What Are the Key Elements That Define the Genital Warts Market?

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Genital Warts Market?

The escalating occurrence of sexually transmitted infections (STIs) is pushing the genital warts market’s expansion forward. STIs, primarily transmitted through sexual activities like vaginal, anal, and oral sex, are infections caused by bacteria, viruses, or parasites. The rampant growth of STIs can be attributed to the increase in sexual activity, insufficient use of protection, and limited access to education and healthcare services. Genital warts, a prevalent form of STI, are caused by certain types of the human papillomavirus (HPV) and are transmitted through direct skin-to-skin contact during sexual intercourse. For example, as per the Switzerland-based Joint United Nations Programme on HIV/AIDS in October 2023, about 38.7 million individuals were infected with HIV in 2021, which surged to 39.0 million in 2022, including 1.3 million new infections in 2022 alone. Therefore, the burgeoning occurrence of STIs is bolstering the expansion of the genital warts market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

How Will the Growth Rate of theGenital Warts Market Impact Industry Trends by 2034?

The market size for genital warts has experienced significant expansion in the past few years. It is projected to escalate from $1.97 billion in 2024 to $2.08 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.7%. Factors contributing to the growth during the historical period include a patient-centered care approach, an amplified emphasis on early detection and treatment, enhanced availability of self-target application therapies, and a rise in clinical trials and recurring incidents of genital warts.

Over the coming years, the market size of genital warts treatments is predicted to experience significant growth, expanding to a value of $2.57 billion in 2029, at a compound annual growth rate (CAGR) of 5.4%. This surge over the projected period can be traced back to factors such as the integration of telemedicine and digital health platforms for distant consultations and treatment oversight, an increasing need for effective and economical solutions for STIs, growing interest in loop electrosurgical excision methods, amplified demand for interferon alfa-n3 injection, and more accessible therapies. The main trends expected in this period include advancements in diagnostic technology, a shift towards combination therapies, the proliferation of telehealth and digital consultations, the introduction of new therapeutic targets, and growth within developing markets.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

What Are the Key Market Innovations in theGenital Warts Market Over the Coming Years?

Major corporations in the genital warts market are pioneering innovative treatment methods, such as newly conceived dermatology drugs, to tackle the difficulties experienced by those suffering from genital warts. Dermatology drugs denote recently constructed pharmaceuticals or therapeutic substances particularly tailored to treat various skin conditions including genital warts. For instance, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical corporation based in the US, obtained New Chemical Entity (NCE) status for YCANTH, its prospective medication, in March 2023. YCANTH, which has finished phase 2 trials, is under development for the treatment of genital warts. Following FDA NCE status, the company enjoys minimally a five-year period of safeguard against generic competition.

Who Are the Top Companies Driving Innovation and Growth in theGenital Warts Market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Key Market Segments Comprise the Genital Warts Market and Drive Its Revenue Growth?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=18374&type=smp

Which Regions Are Emerging as Leaders in the Genital Warts Market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Genital Warts Market 2025, By The Business Research Company:

Cryogenic Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Insulation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

Cryogenic Tanks Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-tanks-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the genital warts market size evolved in recent years?

The market size for genital warts has seen robust growth in the recent past. The market is projected to expand from $1.97 billion in 2024 to $2.08 billion in 2025, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth during the historic period include an amplified focus on patient-oriented care, the endorsement of early diagnosis and treatment, an increase in self-target application therapies, and an uptick in clinical trials and genital warts recurrence.

What are the predictions for the genital warts market size in the coming years?

In the upcoming years, the market size for genital warts is projected to experience substantial growth, increasing to $2.57 billion in 2029 with a compound annual growth rate (CAGR) of 5.4%. The growth during this forecasted time frame can be credited to several factors including, increased application of telemedicine and digital health platforms for remote consultation and treatment monitoring, the rising need for affordable and effective treatments for sexually transmitted infections (STIs), the growing appeal of the loop electrosurgical excision procedures, the surging demand for interferon alfa-n3 injection and the increased availability of treatment options. Additionally, the forecasted period will witness major trends such as advancements in diagnostic technologies, a shift towards combination therapies, further expansion of telehealth and online consultations, the emergence of innovative therapeutic targets, and growth in emerging markets.

Get your genital warts market report here!

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

What key factors are fueling the growth of the genital warts market?

The rise in sexually transmitted infections (STIs) is fueling the expansion of the genital warts market. STIs, which are predominantly passed on through sexual intercourse – vaginal, anal, and oral – are caused by bacteria, viruses, or parasites. The increasing instances of STIs can be attributed to heightened sexual activity, insufficient use of precautionary measures, and restricted access to education and healthcare facilities. Genital warts, a frequently occurring STI, are brought about by specific variants of the human papillomavirus (HPV) and are transmitted through direct skin contact during sexual activity. For instance, in October 2023, the Joint United Nations Programme on HIV/AIDS, a comprehensive program based in Switzerland that aims at preventing HIV infection, reported that the number of HIV-infected individuals rose from 38.7 million in 2021 to 39.0 million in 2022, with an additional 1.3 million people being infected in 2022 alone. Consequently, the escalating prevalence of STIs is propelling the genital warts market’s growth.

How is the global genital warts market divided into key segments?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Who are the key firms paving the way for growth in the genital warts market?

Major companies operating in the genital warts market are Merck & Co.Inc., AbbVie Inc, Sanofi S.A, Novartis AG, 3M Company, Teva Pharmaceutical Industries Ltd, Bausch Health Companies Inc, Sun Pharmaceuticals, Perrigo Company plc, Glenmark Pharmaceutical Inc, Taro Pharmaceutical Industries Ltd, Serum Institute of India Pvt. Ltd., ANI Pharmaceuticals Inc, Ligand Pharmaceuticals Incorporated, Orgenesis Inc, Verrica Pharmaceuticals Inc, CryoConcepts LP, CryoIQ global AB, Cassiopea Inc, Aresus Pharma Inc.

What key trends are currently impacting the genital warts market’s development?

Prominent corporations within the genital warts market are focusing on creating innovative treatment methodologies, for instance, pioneering dermatology medications, to tackle the issues that genital warts patients face. Dermatology medicines encompass recently formed pharmaceuticals or therapeutic substances specifically crafted to cure numerous dermatological conditions like genital warts. For instance, Verrica Pharmaceuticals Inc., a dermatological pharmaceutical firm based in the US, was granted New Chemical Entity (NCE) status for its drug contender YCANTH in March 2023. YCANTH, which is under development for treating genital warts, has successfully completed phase 2 trials. Having obtained FDA NCE status, the corporation is now guaranteed a minimum five-year protection against competition from generic medications.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18374

What regions are contributing significantly to the growth of the genital warts market?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cryogenic Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Insulation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

Cryogenic Tanks Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-tanks-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Growth Potential of the Genital Warts Market, and How Will It Perform by 2034?

In recent years, the market for genital warts has seen robust growth. The market is expected to expand from $1.97 billion in 2024 to $2.08 billion in 2025, displaying a compound annual growth rate (CAGR) of 5.7%. The significant growth during the historic phase can be tied to several factors, including a heightened focus on patient-oriented care, an increased emphasis on early diagnosis and intervention, more readily available self-target application therapies, along with an uptick in clinical trials and recurrence of genital warts.

The market for genital warts is predicted to experience significant expansion in the coming years, reaching a market value of $2.57 billion in 2029, with a compound annual growth rate (CAGR) of 5.4%. The predicted growth in this timeframe can be linked to the increased acceptance of telemedicine and online health platforms for remote consultation and follow-up treatment, a rise in the need for effective and cost-efficient treatments for sexually transmitted infections, the growing trend of loop electrosurgical excision procedures, mounting demand for interferon alfa-n3 injection and the widespread availability of therapies. Key market trends forecasted include progress in diagnostic technologies, a leaning towards combination therapies, the growth of telehealth and virtual consultations, the emergence of new therapeutic targets, and market expansion in developing countries.

Which Drivers Are Expected to Have the Greatest Impact on the Genital Warts Market’s Growth?

The genital warts market’s expansion is being driven by the rising occurrence of sexually transmitted infections (STIs). These are infections primarily spread through sexual activities such as vaginal, anal, and oral sex and they can be caused by bacteria, viruses, or parasites. The growing rate of STIs can be attributed to more sexual activity, insufficient use of protective methods, and lack of access to education and healthcare services. Genital warts are a widespread sexually transmitted infection (STI) caused by specific variants of the human papillomavirus (HPV) and are transferred through direct skin-to-skin contact during sex. For example, the Joint United Nations Programme on HIV/AIDS, based in Switzerland, reported that around 38.7 million people were infected with HIV in 2021 and this number rose to 39.0 million in 2022, with 1.3 million new infections occurring in 2022. Thus, the escalating occurrence of sexually transmitted infections (STIs) is propelling the growth of the genital warts market.

Request Your Free Genital Warts Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=18374&type=smp

Who Are the Major Companies Shaping the Competitive Landscape of the Genital Warts Market?

Major companies operating in the genital warts market are:

• Authentic Brands Group LLC

• Thule Group

• Arena Hospitality Group

• Under Canvas

• Wigwam Holidays Ltd.

What Are the Key Emerging Trends in the Genital Warts Market for the Next Decade?

Leading firms in the genital warts market are progressing in the creation of innovative treatments like cutting-edge dermatology drugs, to confront the struggles experienced by genital warts patients. These dermatology drugs encompass the recently developed pharmaceuticals or therapeutic solutions, specifically created to cure various skin ailments including genital warts. For instance, in March 2023, Verrica Pharmaceuticals Inc., a dermatology pharmaceutical organization based in the US, was granted New Chemical Entity (NCE) status for its investigational drug YCANTH. This drug, which is being developed for the treatment of genital warts, has successfully completed phase 2 trials. Thanks to the FDA NCE status, the company now has a minimum of five years of immunity from generic competitors.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/genital-warts-global-market-report

Which Key Market Segments Comprise the Genital Warts Market and Drive Its Revenue Growth?

The genital warts market covered in this report is segmented –

1) By Drug Type: Imiquimod, Podophyllin, Podofilox, Trichloroacetic Acid

2) By Treatment: Chemical Treatment, Ablative Treatment, Preventive Treatment, Other Treatments

3) By Gender: Female, Male

4) By End Users: Hospitals, Clinics, Home Care Settings

Subsegmments

1) By Imiquimod: Imiquimod Cream 5%, Imiquimod Cream 3.75%

2) By Podophyllin: Podophyllin Resin 10%, Podophyllin Resin 25%

3) By Podofilox: Podofilox Gel 0.5%, Podofilox Solution 0.5%

4) By Trichloroacetic Acid: Trichloroacetic Acid 80-90%, Trichloroacetic Acid 50-70%

Which Regions Are Making a Mark in the Genital Warts Market Growth?

North America was the largest region in the genital warts market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genital warts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Genital Warts Market Categorized and Defined in the Industry?

Genital warts refer to condylomata acuminata, which are sexually transmitted infections (STI) caused by certain strains of the human papillomavirus (HPV). These warts typically appear as small growths or clusters of bumps on or around the genital and anal areas and vary in size and shape, may be raised or flat, and often have a cauliflower-like appearance. Genital warts are usually painless but can cause itching, discomfort, or bleeding during sexual intercourse.

Browse Through More Similar Reports By The Business Research Company:

Cryogenic Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-equipment-global-market-report

Cryogenic Insulation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-insulation-global-market-report

Cryogenic Tanks Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cryogenic-tanks-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: